Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma

Joseph A. Sparano, Richard I. Fisher, Margaret Sunderland, Kim Margolin, Mary Lou Ernest, Mario Sznol, Michael B. Atkins, Janice P. Dutcher, Kenneth C. Micetich, Geoffrey R. Weiss, James H. Doroshow, Frederick R. Aronson, Lawrence V. Rubinstein, James W. Mier

Research output: Contribution to journal › Article › peer-review

177 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences